Drug discovery company identifying and developing therapeutic agents to treat alpha-1 antitrypsin deficiency
Drug discovery company identifying and developing therapeutic agents to treat alpha-1 antitrypsin deficiency. Acquired by Centessa Pharmaceuticals in January 2021.